These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7471110)

  • 21. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
    den Boer AT; van Mierlo GJ; Fransen MF; Melief CJ; Offringa R; Toes RE
    Cancer Res; 2005 Aug; 65(15):6984-9. PubMed ID: 16061684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into the mechanism of TCR-V beta 8+/CD8+ T cell-mediated MOPC-315 tumor eradication.
    Mokyr MB; Prokhorova A; Rubin M; Bluestone JA
    J Immunol; 1994 Oct; 153(7):3123-34. PubMed ID: 8089490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
    Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
    Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia.
    Ben-Efraim S; Bizzini B; Relyveld EH
    Biomed Pharmacother; 2000 Jun; 54(5):268-73. PubMed ID: 10917465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J; Andreeff M; Roth JA; Fang B
    Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term stable expression of antisense cDNA of cyclin B1 profoundly inhibits the proliferation of tumor cells and suppresses tumorigenicity in implanted mice.
    Zhang T; Zhang L; Li JC; Wei D; Wei YQ; Zhang R; Cheng P; Chen XC; Liu HY; Su XM
    Chin Med J (Engl); 2008 Aug; 121(15):1433-8. PubMed ID: 18959122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
    Wang KM; Xia AD; Chen SS
    Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor eradication in the rabbit by radiofrequency heating.
    Dickson JA; Shah SA; Waggott D; Whalley WB
    Cancer Res; 1977 Jul; 37(7 Pt 1):2162-9. PubMed ID: 861943
    [No Abstract]   [Full Text] [Related]  

  • 35. Intra-bone marrow injection of dendritic cells for treatment of malignant tumor in mice.
    Koike-Kiriyama N; Koike Y; Adachi Y; Mukaide H; Minamino K; Shigematsu A; Kamiama Y; Matsumura M; Ikehara S
    J Exp Clin Cancer Res; 2007 Sep; 26(3):337-42. PubMed ID: 17987792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors.
    Tong Y; Song W; Crystal RG
    Cancer Res; 2001 Oct; 61(20):7530-5. PubMed ID: 11606390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
    Anderson LD; Petropoulos D; Everse LA; Mullen CA
    Cancer Res; 1999 Apr; 59(7):1525-30. PubMed ID: 10197624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
    Yang X; Chu Y; Wang Y; Zhang R; Xiong S
    J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro thermal therapy of AT-1 Dunning prostate tumours.
    Bhowmick S; Coad JE; Swanlund DJ; Bischof JC
    Int J Hyperthermia; 2004 Feb; 20(1):73-92. PubMed ID: 14612315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.